ShareValue scores for 603014.SHG: Valuation 60, Quality 57, Growth 50, Health 63.
603014.SHGSSE
Shandong Weigao Blood
CN¥34.19
(+0.71%)
603014.SHGSSE
Shandong Weigao Blood
CN¥34.19(+0.71%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
7% to 17%
Rating
Trap Risk
Return
7% to 17%
Valuation
60
Fair Value
Price vs Value
Quality
57
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
63
Moderate
Financial Stability
Momentum
26
Bearish
Price Trend
Company Details
About
Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers; dialysis machines; hemodialysis tubing, products, and machines; peritoneal dialysis products; dialysis supporting products, such as hemoperfusion devices, dialysis powder and liquid, puncture needles, and iodine caps for peritoneal dialysis. The company was founded in 2004 and is based in Weihai, China.
Market Cap$14.28B
P/E Ratio27.4
Dividend Yield1.54%
Sector Rank#612
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026